“…18 Indeed, echocardiographic abnormalities (Figure 1) have been reported in 14% to 46% of patients with systemic sarcoidosis, even in the absence of symptoms or ECG abnormalities. [19][20][21][22][23] Abnormal findings include wall motion abnormalities, diastolic dysfunction, abnormal myocardial wall thickness in a noncoronary distribution, possibly caused by sarcoid granulomas, or thinning, as a late result of the same process. [20][21][22] In addition, findings of left ventricular dilatation and left ventricular systolic dysfunction, which can be assessed by echocardiography, are predictors of mortality in CS 6,21 Despite the various abnormalities that can be identified by echocardiography, patients with CS may have a normal echocardiogram, and accordingly echocardiography has a low sensitivity to diagnose early or localized mild disease.…”